Literature DB >> 24607488

The effect of the common c.2299delG mutation in USH2A on RNA splicing.

Eva Lenassi1, Zubin Saihan2, Maria Bitner-Glindzicz3, Andrew R Webster4.   

Abstract

Recessive variants in the USH2A gene are an important cause of both Usher syndrome and nonsyndromic retinitis pigmentosa. A single base-pair deletion in exon 13 (c.2299delG, p.Glu767Serfs*21) is considered the most frequent mutation of USH2A. It is predicted to generate a premature termination codon and is presumed to lead to nonsense mediated decay. However the effect of this variant on RNA has not been formally investigated. It is not uncommon for exonic sequence alterations to cause aberrant splicing and the aim of the present report is to evaluate the effect of c.2299delG on USH2A transcripts. Nasal cells represent the simplest available tissue to study splicing defects in USH2A. Nasal brushing, RNA extraction from nasal epithelial cells and reverse transcription PCR were performed in five Usher syndrome patients who were homozygous for c.2299delG, two unaffected c.2299delG heterozygotes and seven control individuals. Primers to amplify between exons 12 and 15 and exons 10 and 14 were utilised. Significant variability was observed between different RT-PCR experiments. Importantly, in controls, PCR product of the expected size were amplified on all occasions (13/13 experiments); for patients this was true in only 4/14 experiments (Fisher exact test p = 0.0002). Bioinformatics tools predict the c.2299delG change to disrupt an exonic splicing enhancer and to create an exonic splicing silencer within exon 13. Here, we report an effect of the common c.2299delG mutation on splicing of exons 12 and 13 of USH2A. Future studies are expected to provide important insights into the contribution of this effect on the phenotype.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  RNA; RT-PCR; USH2A; Usher syndrome; exon skipping; retinitis pigmentosa; splicing

Mesh:

Substances:

Year:  2014        PMID: 24607488     DOI: 10.1016/j.exer.2014.02.018

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  9 in total

1.  Generation of Humanized Zebrafish Models for the In Vivo Assessment of Antisense Oligonucleotide-Based Splice Modulation Therapies.

Authors:  Renske Schellens; Erik de Vrieze; Ralph Slijkerman; Hannie Kremer; Erwin van Wijk
Journal:  Methods Mol Biol       Date:  2022

2.  Usherin defects lead to early-onset retinal dysfunction in zebrafish.

Authors:  Margo Dona; Ralph Slijkerman; Kimberly Lerner; Sanne Broekman; Jeremy Wegner; Taylor Howat; Theo Peters; Lisette Hetterschijt; Nanda Boon; Erik de Vrieze; Nasrin Sorusch; Uwe Wolfrum; Hannie Kremer; Stephan Neuhauss; Jingjing Zang; Maarten Kamermans; Monte Westerfield; Jennifer Phillips; Erwin van Wijk
Journal:  Exp Eye Res       Date:  2018-05-16       Impact factor: 3.467

3.  Molecular Epidemiology in 591 Italian Probands With Nonsyndromic Retinitis Pigmentosa and Usher Syndrome.

Authors:  Leonardo Colombo; Paolo E Maltese; Marco Castori; Said El Shamieh; Christina Zeitz; Isabelle Audo; Alessandra Zulian; Carla Marinelli; Sabrina Benedetti; Alisia Costantini; Simone Bressan; Marcella Percio; Paolo Ferri; Andi Abeshi; Matteo Bertelli; Luca Rossetti
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-02-01       Impact factor: 4.799

4.  Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations.

Authors:  Kalyan Dulla; Ralph Slijkerman; Hester C van Diepen; Silvia Albert; Margo Dona; Wouter Beumer; Janne J Turunen; Hee Lam Chan; Iris A Schulkens; Lars Vorthoren; Cathaline den Besten; Levi Buil; Iris Schmidt; Jiayi Miao; Hanka Venselaar; Jingjing Zang; Stephan C F Neuhauss; Theo Peters; Sanne Broekman; Ronald Pennings; Hannie Kremer; Gerard Platenburg; Peter Adamson; Erik de Vrieze; Erwin van Wijk
Journal:  Mol Ther       Date:  2021-04-23       Impact factor: 12.910

5.  A novel USH2A variant in a patient with hearing loss and prenatal diagnosis of a familial fetus: a case report.

Authors:  Shanling Liu; Jing Wang; Cong Zhou; Yuanyuan Xiao; Hanbing Xie
Journal:  BMC Med Genomics       Date:  2021-08-10       Impact factor: 3.063

Review 6.  Advancing precision medicines for ocular disorders: Diagnostic genomics to tailored therapies.

Authors:  Priyalakshmi Panikker; Shomereeta Roy; Anuprita Ghosh; B Poornachandra; Arkasubhra Ghosh
Journal:  Front Med (Lausanne)       Date:  2022-07-15

Review 7.  Genetics, pathogenesis and therapeutic developments for Usher syndrome type 2.

Authors:  M Stemerdink; B García-Bohórquez; R Schellens; G Garcia-Garcia; E Van Wijk; J M Millan
Journal:  Hum Genet       Date:  2021-07-30       Impact factor: 4.132

8.  CDHR1 mutations in retinal dystrophies.

Authors:  Katarina Stingl; Anja K Mayer; Pablo Llavona; Lejla Mulahasanovic; Günther Rudolph; Samuel G Jacobson; Eberhart Zrenner; Susanne Kohl; Bernd Wissinger; Nicole Weisschuh
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

Review 9.  Usher syndrome: clinical features, molecular genetics and advancing therapeutics.

Authors:  Maria Toms; Waheeda Pagarkar; Mariya Moosajee
Journal:  Ther Adv Ophthalmol       Date:  2020-09-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.